Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Garth Powis

Showing results (91-100 of 100) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 100 results.
Cancer Research|May 2, 2019
An Inhibitor of the Pleckstrin Homology Domain of CNK1 Selectively Blocks the Growth of Mutant KRAS Cells and TumorsMartin Indarte, Roisin Puentes, Marco Maruggi, et al.
Experimental Cell Research|November 20, 2021
PLEKHA7 signaling is necessary for the growth of mutant KRAS driven colorectal cancerHei-Cheul Jeung, Roisin Puentes, Alexander Aleshin, et al.
Cancer Letters|December 3, 2014
A pathway-based approach for identifying biomarkers of tumor progression to trastuzumab-resistant breast cancerSeungyoon Nam, Hae Ryung Chang, Hae Rim Jung, et al.
Molecular Cancer Therapeutics|May 5, 2017
Modeling of Patient-Derived Xenografts in Colorectal CancerAnastasia Katsiampoura, Kanwal Raghav, Zhi-Qin Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2012
Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agentsMuling Mao, Feng Tian, John M Mariadason, et al.
Cancer Research|March 22, 2012
AMPKα modulation in cancer progression: multilayer integrative analysis of the whole transcriptome in Asian gastric cancerYon Hui Kim, Han Liang, Xiuping Liu, et al.
Molecular Cancer Research : MCR|March 3, 2011
HIF-1-dependent stromal adaptation to ischemia mediates in vivo tumor radiation resistanceDavid L Schwartz, James Bankson, Luc Bidaut, et al.
Gut|November 21, 2014
HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancerHae Ryung Chang, Seungyoon Nam, Myeong-Cherl Kook, et al.
Journal of the National Cancer Institute|January 17, 2012
Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcomeNathan T Ihle, Lauren A Byers, Edward S Kim, et al.
International Journal of Radiation Biology|November 23, 2006
Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapyJames L Tatum, Gary J Kelloff, Robert J Gillies, et al.
Pageof 10

Showing results (91-100 of 100) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 100 results.
Cancer Research|May 2, 2019
An Inhibitor of the Pleckstrin Homology Domain of CNK1 Selectively Blocks the Growth of Mutant KRAS Cells and TumorsMartin Indarte, Roisin Puentes, Marco Maruggi, et al.
Experimental Cell Research|November 20, 2021
PLEKHA7 signaling is necessary for the growth of mutant KRAS driven colorectal cancerHei-Cheul Jeung, Roisin Puentes, Alexander Aleshin, et al.
Cancer Letters|December 3, 2014
A pathway-based approach for identifying biomarkers of tumor progression to trastuzumab-resistant breast cancerSeungyoon Nam, Hae Ryung Chang, Hae Rim Jung, et al.
Molecular Cancer Therapeutics|May 5, 2017
Modeling of Patient-Derived Xenografts in Colorectal CancerAnastasia Katsiampoura, Kanwal Raghav, Zhi-Qin Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2012
Resistance to BRAF inhibition in BRAF-mutant colon cancer can be overcome with PI3K inhibition or demethylating agentsMuling Mao, Feng Tian, John M Mariadason, et al.
Cancer Research|March 22, 2012
AMPKα modulation in cancer progression: multilayer integrative analysis of the whole transcriptome in Asian gastric cancerYon Hui Kim, Han Liang, Xiuping Liu, et al.
Molecular Cancer Research : MCR|March 3, 2011
HIF-1-dependent stromal adaptation to ischemia mediates in vivo tumor radiation resistanceDavid L Schwartz, James Bankson, Luc Bidaut, et al.
Gut|November 21, 2014
HNF4α is a therapeutic target that links AMPK to WNT signalling in early-stage gastric cancerHae Ryung Chang, Seungyoon Nam, Myeong-Cherl Kook, et al.
Journal of the National Cancer Institute|January 17, 2012
Effect of KRAS oncogene substitutions on protein behavior: implications for signaling and clinical outcomeNathan T Ihle, Lauren A Byers, Edward S Kim, et al.
International Journal of Radiation Biology|November 23, 2006
Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapyJames L Tatum, Gary J Kelloff, Robert J Gillies, et al.
Pageof 10